BACKGROUND Prothrombin complex concentrate (PCC) is widely used to reverse the action of direct oral anticoagulants (DOACs) in accordance with current guidelines and because of a lack of specific reversal agents. Indications, clinical characteristics and patient outcomes of patients might differ in comparison to reversal of vitamin K antagonists where reversal with PCC is well established. METHODS Our cohort study explores patient characteristics, indications and clinical outcomes for reversal of all DOAC patients receiving PCC at our university emergency department from 01.06.2012 to 01.07.2017, in comparison with patients on VKA. RESULTS Out of 199,982 consultations, we studied 346 patients who were given PCC for reversal o...
Purpose: To evaluate appropriate usage of 4-factor PCC based on indication and dosage in patients re...
BackgroundDespite years of experience with vitamin K antagonist-associated bleeding events, there is...
Anticoagulation is a necessary component of modern healthcare and is used to treat thromboembolic co...
Abstract Background Prothrombin complex concentrate (PCC) is widely used to reverse the action of di...
The direct oral anticoagulants (DOACs), or non-vitamin K antagonist oral anticoagulants (NOACs), inc...
Introduction Prothrombin complex concentrates are recommended for rapid reversal of vitamin K antico...
International audienceABSTRACT: INTRODUCTION: Prothrombin Complex Concentrate (PCC) is a key treatme...
International audienceINTRODUCTION: Prothrombin complex concentrate (PCC) for reversal of vitamin K ...
Intracranial hemorrhage (ICH) is the most feared complication of anticoagulation with a high mortali...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
International audienceINTRODUCTION: In vitamin K antagonist (VKA)-treated patients with severe hemor...
Background: Vitamin K antagonists (VKA) are used for the treatment of thromboembolism. Patients with...
Direct oral anticoagulants are at least as effective as vitamin K antagonists for the prevention and...
Purpose: To evaluate appropriate usage of 4-factor PCC based on indication and dosage in patients re...
BackgroundDespite years of experience with vitamin K antagonist-associated bleeding events, there is...
Anticoagulation is a necessary component of modern healthcare and is used to treat thromboembolic co...
Abstract Background Prothrombin complex concentrate (PCC) is widely used to reverse the action of di...
The direct oral anticoagulants (DOACs), or non-vitamin K antagonist oral anticoagulants (NOACs), inc...
Introduction Prothrombin complex concentrates are recommended for rapid reversal of vitamin K antico...
International audienceABSTRACT: INTRODUCTION: Prothrombin Complex Concentrate (PCC) is a key treatme...
International audienceINTRODUCTION: Prothrombin complex concentrate (PCC) for reversal of vitamin K ...
Intracranial hemorrhage (ICH) is the most feared complication of anticoagulation with a high mortali...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
International audienceINTRODUCTION: In vitamin K antagonist (VKA)-treated patients with severe hemor...
Background: Vitamin K antagonists (VKA) are used for the treatment of thromboembolism. Patients with...
Direct oral anticoagulants are at least as effective as vitamin K antagonists for the prevention and...
Purpose: To evaluate appropriate usage of 4-factor PCC based on indication and dosage in patients re...
BackgroundDespite years of experience with vitamin K antagonist-associated bleeding events, there is...
Anticoagulation is a necessary component of modern healthcare and is used to treat thromboembolic co...